Bernd Zeiss, Manager Technical Presales Support in Gerresheimer’s Business Development Unit, will be talking about “New Developments and Trends in the Prefillable Syringe System Segment“ at the Pharmtech Forum from 12:05 to 12:35 on 24 November.
Today, chronically ill people can administer their medication simply and reliably with asthma inhalers and insulin pens. However, even when patients receive an injection from their doctor, use a nasal spray to relieve cold symptoms, take cough medicine or tablets, they also often come into contact with Gerresheimer products because it makes the glass or plastic vials or tablet containers.
The Tubular Glass Division is showcasing a range of prefillable syringes, including its flagship RTF® sterile syringes. Tubular glass is the input material for a comprehensive range of high quality pharmaceutical vials, ampoules and cartridges in numerous filling sizes and design variants.
The Moulded Glass division manufactures high-quality injection, infusion and transfusion bottles as well as dropper and tablet bottles of various types, shapes and sizes in glass categories I, II and III.
The flagship products being showcased by the Plastic Packaging division are multilayer plastic vials for sensitive parenteral medications. This division has established a leading reputation for its comprehensive range of high quality primary packaging products for liquid and solid medications.
About Gerresheimer
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of around one billion euros and has around 10,000 employees at 45 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.
Press contacts
Jens Kürten
Director Corporate Communication & Marketing
Telephone: +49 211 6181-250
Fax: +49 211 6181-241
E-Mail: j.kuerten@gerresheimer.com
Marion Stolzenwald
Senior Manager Corporate Communication
Telephone: +49 211 6181-246
Fax: +49 211 6181-241
E-Mail: m.stolzenwald@gerresheimer.com
Gerresheimer at Pharmtech 2011: innovative solutions for health and well-being
Date: 24 November 2011
Source: http://www.worldpressonline.com
Düsseldorf, 17 November 2011 - At Pharmtech in Moscow from 22 to 25 November in Hall 8, Booth B08, Gerresheimer will be presenting innovative solutions for the pharma industry.